Cipla LtdNSE: CIPLA

Press Release Aug 12 2021

· Issued by Cipla Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-12-2021-1

Cipla Limited has informed the Exchange regarding a press release dated August 12, 2021, titled "Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol�� (Difluprednate Ophthalmic Emulsion 0.05%)".

View Attachment

6ix hasn’t read this filing yet.

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases